ChromaDex Reports Record Revenue and Quarterly Net Income as Ingredients Sales Climb 72%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Chromadex Corporation (CDXC) Swing to Q1 Profit
May 12, 2016 6:47 AM EDTChromadex Corporation (NASDAQ: CDXC) reported Q1 EPS of $0.01, versus ($0.03) reported last year. Revenue for the quarter came in at $7.3 million, versus $5.3 million reported last year.
For earnings history and earnings-related data on Chromadex Corporation (CDXC) click here.
... More